Pharma
Pharma·
Onco-Innovations Limited: Successful Scaling of the Pharmaceutical Active Ingredient A83B4C63 and Appointment of a New CFO
Pharma·
US Government Investigates Drug Prices in Germany: A Warning Signal for the Pharmaceutical Industry
Pharma·
Novo Nordisk: Challenges and Opportunities in Focus for Investors
Pharma·
Onco-Innovations Successfully Completes Project with Kuano and Optimizes PNKP Inhibitor Technology
Pharma·
BioNxt Solutions Inc. Focuses on Strategic Partnerships for Marketing BNT23001
Pharma·
Vidac Pharma Holding PLC: Recruitment in Phase 2B Study with VDA-1102 Successfully Completed
Pharma·
Onco-Innovations Starts Process Development for Innovative PNKP Inhibitor Technology
Pharma·
Eli Lilly's Next-Gen Weight-Loss Drug Sparks Shareholder Optimism
Pharma·
Zealand Pharma Faces Setback as Weight-Loss Drug Trial Sees High Discontinuation Rates
Pharma·
Pharmaceutical Industry Under Pressure: Challenges from New Discount Regulations
Pharma·
Wegovy Continues to Lead the GLP-1 Market Despite New Entrants
Pharma·
Pharmaceutical Industry in Germany Under Pressure: Investment Cancellations as a Warning Signal
Pharma·
Emerging Weight-Loss Therapies Poised to Outshine GLP-1s
Pharma·
Pharmaceutical Industry in Germany: Warning Signals from Canceled Investments
Pharma·
Merck to Settle Gardasil Lawsuits for $50 Million: A Strategic Move Amid Controversy
Pharma·
Roche Chairman Accuses US Government of Drug Price ‘Blackmail’
Pharma·
Gedeon Richter Presents Growing Biosimilar Portfolio at EULAR 2026
Pharma·
Parabilis Medicines Aims for $475 Million IPO to Accelerate Cancer Drug Development
Pharma·
Earli's Roeding Highlights China's Biotech Ascendancy
Pharma·
Lilly and BioNTech Sound Alarm on German Health Reforms Impacting Investment
Pharma·
Eli Lilly Expands Genetic Medicine Footprint with $1.9 Billion Ascidian Pact
Pharma·
Boehringer Ingelheim Stops Billion-Euro Investments in Germany
Pharma·
Boehringer Ingelheim Stops Investments in Germany: A Signal for the Pharmaceutical Industry
Pharma·
Onco-Innovations: Advances in Scaling B4 Precursor Production and New Marketing Program
Pharma·
MindWalk Holdings Corp. Presents Promising Preclinical Data for Dengue Vaccine Development
Pharma·
Abivax's Ulcerative Colitis Breakthrough: A Catalyst for Growth and Acquisition
Pharma·
Barclays Recommends Astrazeneca: Positive Outlook for the Datroway Program
Pharma·
‘King Keytruda’ Faces New Challenger as Ivonescimab Shows Promise
Pharma·
Apotex Health Aims for C$1.2 Billion IPO: A Growth Opportunity in the Generic Drug Market
Pharma·